Renaissance Technologies
TTHI

Renaissance Technologies’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Renaissance Technologies’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-281,400
Closed -$414K – 3695
2016
Q2 		$414K Buy
281,400
+20,400
+8% +$17.7K ﹤0.01% 2852
2016
Q1 		$334K Buy
261,000
+24,600
+10% +$28.4K ﹤0.01% 2960
2015
Q4 		$454K Buy
236,400
+32,200
+16% +$61.1K ﹤0.01% 2767
2015
Q3 		$366K Buy
204,200
+24,900
+14% +$53K ﹤0.01% 2716
2015
Q2 		$377K Sell
179,300
-11,400
-6% -$79.9K ﹤0.01% 2806
2015
Q1 		$1.3M Buy
190,700
+15,300
+9% +$106K ﹤0.01% 2170
2014
Q4 		$1.2M Buy
175,400
+25,700
+17% +$166K ﹤0.01% 2050
2014
Q3 		$1.03M Buy
149,700
+18,400
+14% +$124K ﹤0.01% 2013
2014
Q2 		$882K Buy
131,300
+200
+0.2% +$1.16K ﹤0.01% 2111
2014
Q1 		$1.04M Buy
131,100
+11,300
+9% +$77.8K ﹤0.01% 2062
2013
Q4 		$682K Buy
119,800
+47,400
+65% +$243K ﹤0.01% 2249
2013
Q3 		$296K Buy
72,400
+41,700
+136% +$164K ﹤0.01% 2474
2013
Q2 		$99K Buy
+30,700
New +$87.1K ﹤0.01% 2627

Other funds holding TTHI

HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Renaissance Technologies's TTHI Position: Q3 2016 in Review

Renaissance Technologies sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2016, closing a stake of 281,400 shares — an estimated $414K sold.

Renaissance Technologies first reported a position in TTHI in Q2 2013 and held it in 13 quarters. The position peaked at $1.3M in Q1 2015. 2 funds tracked by Wall St. Rank hold TTHI as of Q3 2016.

  • Renaissance Technologies reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2016 after selling out during the quarter.
  • Renaissance Technologies sold 281,400 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2016, an estimated $414K.
  • Renaissance Technologies first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2013 and held it in 13 quarters.
  • Renaissance Technologies's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $1.3M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2016.

Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.